Educational Wellness Information Only
This platform provides peer-reviewed research summaries and educational content about peptides for wellness and optimization purposes. Nothing on this site is intended as medical advice, diagnosis, or treatment. We do not claim any peptide can diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any wellness protocol.
Statements on this site have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability and eligibility vary.
IGF-1 LR3 vs Somatrogon (Ngenla)
An educational, source-based comparison of IGF-1 LR3 and Somatrogon (Ngenla) — how each peptide works, what it's researched for, and what to know before going deeper.
A modified form of insulin-like growth factor-1 with an Arg3 substitution and N-terminal extension that reduces binding to IGFBPs, dramatically extending its half-life and free fraction in circulation.
- Muscle protein synthesis (preclinical)
- Tissue repair signaling
- Cell-culture growth applications
- • Hypoglycemia risk via insulin-receptor cross-activity.
- • Not FDA-approved for human therapeutic use; banned by WADA.
Long-acting recombinant human growth hormone for pediatric GH deficiency — weekly dosing.
A long-acting recombinant fusion protein of human growth hormone with three copies of the C-terminal peptide (CTP) of hCG beta-subunit, extending half-life and enabling once-weekly subcutaneous dosing instead of daily.
- Pediatric growth hormone deficiency
- • FDA-approved June 2023.
- • Same class warnings as daily GH (intracranial hypertension, glucose effects, scoliosis progression).
- • Injection-site reactions common.
IGF-1 LR3 vs Somatrogon (Ngenla) — Key differences
- Class: IGF-1 LR3 is classified as Growth Factor, while Somatrogon (Ngenla) is GH Analog · Endocrine.
- Primary research focus: IGF-1 LR3 — muscle protein synthesis (preclinical); Somatrogon (Ngenla) — pediatric growth hormone deficiency.
- Tag: Growth · Recovery vs FDA-Approved · Endocrine.